6-PYRIMIDIN-ISOINDOLE DERIVATIVE AS ERK1/2 INHIBITOR

This invention relates to the compound (2R)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4-yl}-1 -oxo-2,3-dihydro-1 H-isoindol-2-yl)-N-[(1 S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide, and in particular to novel physical forms of the compound, a process for preparing the compound and s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mirka SCARATI, Michael READER, Colin Thomas LINDLEY, Bozena Ewa ADAMCZYK, Mark Henry SAUNDERS, Robert Craig MELLING, Paul Anthony BAGULEY, Nicola Elizabeth WILSHER
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This invention relates to the compound (2R)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4-yl}-1 -oxo-2,3-dihydro-1 H-isoindol-2-yl)-N-[(1 S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide, and in particular to novel physical forms of the compound, a process for preparing the compound and synthetic intermediates for use in the process, and novel formulations containing the compound, as well as therapeutic uses of the compound. La presente invención se refiere al compuesto (2R)-2-(6-{5-cloro-2-[(oxan-4-il)amino]pirimidin-4-il}-1-oxo-2,3- dihidro-1H-isoindol-2-il)-N-[(1S)-1-(3-f luoro-5-metoxifenil)-2-hi droxietil]propanamida, y en particular a formas físicas novedosas del compuesto, un proceso para preparar el compuesto e intermedios sintéticos para usar en el proceso, y formulaciones novedosas que contienen el compuesto, así como también usos terapéuticos del compuesto.